drugset

Drugs / Allogeneic umbilical cord-derived human mesenchymal stromal cells

Follow last change 3 days ago re-read 3 minutes ago

Allogeneic umbilical cord-derived human mesenchymal stromal cells

also known as UC-MSCs · Umbilical Cord Mesenchymal Stromal Cells

Developed for: infectious disease with sepsis
Investigated by: Canadian Critical Care Trials Group · Canadian Institutes of Health Research (CIHR) · Ottawa Hospital Research Institute · Stem Cell Network · Technical University Dresden

Trials 1

today NCT05969275 · Ph 2

20252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2	NCT05969275	Feb 2024 → Sep 2026 overdue	infectious disease with sepsis	Ottawa Hospital Research Institute	Recruiting	No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Allogeneic umbilical cord-derived human mesenchymal stromal cells	ClinicalTrials.gov intervention name — accepted as the source's own label NCT05969275 ↗
Known as	UC-MSCs	“Umbilical Cord Mesenchymal Stromal Cells (UC-MSCs)” NCT05969275 ↗
Known as	Umbilical Cord Mesenchymal Stromal Cells	“Umbilical Cord Mesenchymal Stromal Cells (UC-MSCs)” NCT05969275 ↗
Modality	Cell therapy	“Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy” NCT05969275 ↗
Route	Intravenous	“Intravenous infusion” NCT05969275 ↗